|
| Exchange Disseminated Time | Orchid Chemicals & Pharmaceuticals Ltd has informed BSE regarding a Press Release dated May 02, 2012 titled "Orchid Pharma receives US FDA approval for Naratriptan Tabs ANDA".
Press Release :
"The Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid Pharma) today announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Naratriptan Tablets in the 1 mg and 2.5 mg strengths." (For more details kindly refer Corporate Announcements on www.bseindia.com). |
|
|